SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
August 29, 2019
Document Date
June 30, 2019
Form Description
Amendment to a previously filed 6-K
Filing Group
Current Reports
Company
VBL Therapeutics
Issuer
Vascular Biogenics Ltd.